Android Apple

Halozyme Therapeutics, Inc. (NASDAQ:HALO) Downgraded by Piper Sandler

By Yahoo! Finance   |   6 months ago
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Downgraded by Piper Sandler

Analysts on Wall Street lowered ratings for 10 stocks, with Halozyme Therapeutics, Inc. among them. Market movements are cautiously optimistic ahead of crucial US inflation data and the Fed's monetary policy decision.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.